1-7 of 7
Alexander S Gallus
Close
Save search
Sort by
Journal Articles

Time in Therapeutic Range (TTR) and Relative Efficacy and Safety of Treatment with Apixaban or Enoxaparin/Warfarin for Acute Symptomatic Venous Thromboembolism: An Analysis of the Amplify Trial Data

Free
Alexander Cohen, MD, Alexander S. Gallus, MD, Giancarlo Agnelli, MD, Harry R Buller, MD PhD, Raphael Pak, PhD, Anthony R. Porcari, PhD PharmD, Gary E. Raskob, PhD, Jeffrey I. Weitz, MDFRCPC, Takaharu Yamabe, PhD
Journal: Blood
Blood (2014) 124 (21): 1543.
https://doi.org/10.1182/blood.V124.21.1543.1543
Published: 2014
Journal Articles

Two Doses of Apixaban for the Extended Treatment of Venous Thromboembolism

Free
Giancarlo Agnelli, MD, Harry Roger Buller, MD, PhD, Alexander Cohen, MD, Madelyn Curto, DVM, Alexander S. Gallus, M.D., Margot R. Johnson, MD, BSC, Anthony R. Porcari, PhD, PharmD, Gary E Raskob, PhD, Jeffrey I. Weitz, MD
Journal: Blood
Blood (2012) 120 (21): LBA-1.
https://doi.org/10.1182/blood.V120.21.LBA-1.LBA-1
Published: 2012
Journal Articles

Apixaban Versus Enoxaparin for Thromboprophylaxis After Joint Replacement Surgery: Pooled Analysis of Major Venous Thromboembolism and Bleeding In 8,464 Patients From the ADVANCE 2 and 3 Trials

Free
Gary E. Raskob, Ph.D., Alexander S. Gallus, M.D., Graham F. Pineo, M.D., Dalei Chen, Ph.D., Luz Margarita Ramirez, M.D., Michael Rud Lassen, M.D.
Journal: Blood
Blood (2010) 116 (21): 192.
https://doi.org/10.1182/blood.V116.21.192.192
Published: 2010
Journal Articles

Randomized Double-Blind Comparison of Apixaban with Enoxaparin for Thromboprophylaxis after Knee Replacement: The ADVANCE-1 Trial

Free
Michael Rud Lassen, MD, Alexander S Gallus, MD, Graham F Pineo, MD, Gary E Raskob, PhD, the ADVANCE-1 Investigators
Journal: Blood
Blood (2008) 112 (11): 31.
https://doi.org/10.1182/blood.V112.11.31.31
Published: 2008
Journal Articles

Idrabiotaparinux, a Biotinylated Long-Acting Anticoagulant, in the Treatment of Deep Venous Thrombosis (EQUINOX Study): Safety, Efficacy, and Reversibility by Avidin

Free
Harry Roger Buller, MD, PhD, Jean-Michel Destors, Alexander S. Gallus, MD, Martin H Prins, MD, PhD, Gary Edward Raskob, PhD
Journal: Blood
Blood (2008) 112 (11): 32.
https://doi.org/10.1182/blood.V112.11.32.32
Published: 2008
Journal Articles

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

Free
Clinical Trials & Observations
Harry R. Buller, Anthonie W. A. Lensing, Martin H. Prins, Giancarlo Agnelli, Alexander Cohen, Alexander S. Gallus, Frank Misselwitz, Gary Raskob, Sebastian Schellong, Annelise Segers
Journal: Blood
Blood (2008) 112 (6): 2242–2247.
https://doi.org/10.1182/blood-2008-05-160143
Published: 2008
Includes: Supplemental data
Journal Articles

Benefit of Fondaparinux in Medical Patients: A Subgroup Analysis.

Free
Alexander T. Cohen, Alexander S. Gallus, Bruce L. Davidson, Michael R. Lassen, Martin H. Prins, Witold Tomkowski, Alexander G.G. Turpie, Jan F.M. Egberts, Anthonie W.A. Lensing
Journal: Blood
Blood (2004) 104 (11): 4079.
https://doi.org/10.1182/blood.V104.11.4079.4079
Published: 2004